2022
DOI: 10.31083/j.fbl2704138
|View full text |Cite
|
Sign up to set email alerts
|

Pteropine Orthoreovirus, PRV7S (Sikamat Virus) Demonstrates Oncolysis in Nasopharyngeal Carcinoma Cell Lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Real‐time PCR was performed using SensiFAST SYBR kit (Bioline). Modified primers sequences of PRVSig1F2 5′‐TGCTGATTGGAAYGCTGACT‐3′ and PRVSig1R2 5′‐CKGAAAAGGYTTGAKACGCC‐3′ were used for quantification of PRV by targeting the Sigma 1/A gene 8,19 . The qPCR protocol started with 95°C for 3 min followed by 40 cycles of 95°C for 10 s then 57°C for 30 s and the last step was 72°C for 50 s, with data collection and real‐time analysis by iQ5 real‐time PCR detection system (Bio‐Rad Laboratories).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Real‐time PCR was performed using SensiFAST SYBR kit (Bioline). Modified primers sequences of PRVSig1F2 5′‐TGCTGATTGGAAYGCTGACT‐3′ and PRVSig1R2 5′‐CKGAAAAGGYTTGAKACGCC‐3′ were used for quantification of PRV by targeting the Sigma 1/A gene 8,19 . The qPCR protocol started with 95°C for 3 min followed by 40 cycles of 95°C for 10 s then 57°C for 30 s and the last step was 72°C for 50 s, with data collection and real‐time analysis by iQ5 real‐time PCR detection system (Bio‐Rad Laboratories).…”
Section: Methodsmentioning
confidence: 99%
“…Cells were observed for cytopathic effect (CPE) for 5 days postinfection and the titers were expressed as TCID 50 /ml. Multiplicity of infection (MOI) was calculated based on the TCID 50 as previously described 19 . For virus kinetic study, OKF‐6, NP69 and AC16 cells were infected with 12MYKLU1034, PRV3M or PRV4K, respectively, at a MOI of 0.1.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Oncolytic viruses have been genetically engineered to express cytokines, costimulatory molecules, immune checkpoint inhibitors, or bispecific T-cell engager (BiTE) molecules to boost anti-tumour immune response and suppress tumour tolerance. For instance, an oncolytic adenovirus MG1 encoding HPV oncogenes E6 and E7 demonstrated tumour-specific responses in preclinical studies and is currently undergoing a phase I clinical trial involving patients with HPV-associated malignancies ( Wang et al, 2011 ; Loh et al, 2022 ; Tan et al, 2022 ). Thus, oncolytic viruses represent attractive targets for the development of therapeutic tools against EBV-associated NPC.…”
Section: Ongoing Clinical and Preclinical Studies On Therapeutic Targ...mentioning
confidence: 99%